148 related articles for article (PubMed ID: 21968663)
21. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study.
Chatterjee D; Ghosh SK; Sen S; Sarkar S; Hazra A; De R
Indian J Pharmacol; 2016; 48(6):659-664. PubMed ID: 28066103
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive management of patients with superficial fungal infections: the role of sertaconazole nitrate.
Del Rosso JQ
Cutis; 2008 Jun; 81(6 Suppl):4-18; quiz 19-20. PubMed ID: 18693645
[TBL] [Abstract][Full Text] [Related]
23. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
Elewski BE; Vlahovic TC
J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Signs and Symptoms (Pruritus) of Interdigital Tinea Pedis With Econazole Nitrate Foam, 1.
Hoffman LK; Raymond I; Kircik L
J Drugs Dermatol; 2018 Feb; 17(2):229-232. PubMed ID: 29462232
[TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis.
Das A; Sil A; Sarkar TK; Sen A; Chakravorty S; Sengupta M; Das A; Chandra S; Pal S; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2019; 85(3):276-281. PubMed ID: 30409926
[TBL] [Abstract][Full Text] [Related]
26. Sertaconazole 2% cream vs. miconazole 2% cream for cutaneous mycoses: a double-blind clinical trial.
Ghaninejad H; Gholami K; Hashemi P; Hajibabai M; Rahbar Z; Farivar MS; Mastani F; Rashidi A
Clin Exp Dermatol; 2009 Dec; 34(8):e837-9. PubMed ID: 19793095
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the efficacity and speed of action of sertaconazole nitrate suppository and cream combined treatment for vulvovaginal candidiasis].
Quereux C; Gelas B; Chevallier T; Petit F; Micheletti MC
Gynecol Obstet Fertil; 2000 Mar; 28(3):238-44. PubMed ID: 10786405
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis.
Borelli C; Klövekorn G; Ernst TM; Bödeker RH; Korting HC; Neumeister C
Am J Clin Dermatol; 2007; 8(6):371-8. PubMed ID: 18039020
[TBL] [Abstract][Full Text] [Related]
29. Sertaconazole in the treatment of pediatric patients with cutaneous dermatophyte infections.
Van Esso D; Fajo G; Losada I; Vilallonga M; Casanovas JM; Clanxet J; Aliaga A
Clin Ther; 1995; 17(2):264-9. PubMed ID: 7614526
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory and anti-itch activity of sertaconazole nitrate.
Liebel F; Lyte P; Garay M; Babad J; Southall MD
Arch Dermatol Res; 2006 Sep; 298(4):191-9. PubMed ID: 16868738
[TBL] [Abstract][Full Text] [Related]
31. Treatment of tinea pedis with a single pulse of itraconazole.
Bonifaz A; Saúl A
Eur J Dermatol; 2002; 12(2):157-9. PubMed ID: 11872413
[TBL] [Abstract][Full Text] [Related]
32. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
[TBL] [Abstract][Full Text] [Related]
33. Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs. tacrolimus 0.03% cream.
Goldust M; Rezaee E; Raghifar R; Hemayat S
Ann Parasitol; 2013; 59(2):73-7. PubMed ID: 24171300
[TBL] [Abstract][Full Text] [Related]
34. [Fundamental and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 2. Clinical evaluation].
Watanabe S; Takahashi H; Nakamura Y; Nakamura E; Nishiyama Y; Teduka M; Yamaguchi H; Uchida K; Tomizawa T; Shimozuma M; Osada A; Kawano S; Nakauchi Y; Wakukawa M; Goto A; Ueda Y; Matsukawa A; Minami H; Arikawa J; Soma Y; Chi HI; Tamaki K
Jpn J Antibiot; 1996 Dec; 49(12):1095-108. PubMed ID: 9032596
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor.
Nasarre J; Umbert P; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):764-7. PubMed ID: 1627203
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
[TBL] [Abstract][Full Text] [Related]
37. Sertaconazole: updated review of a topical antifungal agent.
Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G
Expert Rev Anti Infect Ther; 2005 Jun; 3(3):333-42. PubMed ID: 15954850
[TBL] [Abstract][Full Text] [Related]
38. Hyperkeratotic chronic tinea pedis treated with neticonazole cream. Neticonazole Study Group.
Tsuboi R; Matsumoto T; Ogawa H
Int J Dermatol; 1996 May; 35(5):371-3. PubMed ID: 8734665
[No Abstract] [Full Text] [Related]
39. Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis.
Carrillo-Muñoz AJ; Tur-Tur C; Giusiano G; Marcos-Arias C; Eraso E; Jauregizar N; Quindós G
Expert Rev Anti Infect Ther; 2013 Apr; 11(4):347-58. PubMed ID: 23566144
[TBL] [Abstract][Full Text] [Related]
40. Antiinflammatory activity of topically applied sertaconazole nitrate.
Agut J; Tarrida N; Sacristán A; Ortiz JA
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):233-4. PubMed ID: 8803954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
